Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
sector : Health technology symbols : Ppruy save search
Eyewear Market size to record USD 98.28 mn growth from 2024-2028, Increasing adoption of omnichannel distribution system and digital marketing is one of the key market trends, Technavio
Published: 2024-03-28 (Crawled : 08:00) - prnewswire.com
PPRUF | News | $361.9 37.56% 4.3K
|
Consumer Non-Durables
|
| O: 0.43%
H: 0.45%
C: 0.45%
PPRUY | News | $36.03 -0.11% 330K
|
Manufacturing
|
| O: -0.73%
H: 0.41%
C: 0.1%
BHC | $8.6 -0.69% 0.0% 2.1M
|
Health Technology
|
| O: -0.29%
H: 3.25%
C: 1.43%
ALC | $78.47 -0.67% -0.01% 760K
|
Health Technology
|
| O: -0.48%
H: 0.99%
C: 0.49%
distribution one system key growth market
BiomX Announces Closing of the Acquisition of Adaptive Phage Therapeutics and Concurrent $50 Million Financing
Published: 2024-03-18 (Crawled : 11:00) - globenewswire.com
PPRUF | News | $361.9 37.56% 4.3K
|
Consumer Non-Durables
|
| O: -0.49%
H: 2.65%
C: 2.65%
PPRUY | News | $36.03 -0.11% 330K
|
Manufacturing
|
| O: -0.43%
H: 0.02%
C: -0.5%
PHGE | News | $0.2937 4.86% 0.1% 110K
|
Health Technology
|
| O: 1.09%
H: 3.38%
C: -2.7%
million acquisition therapeutics
BiomX Announces Entry into Merger Agreement with Adaptive Phage Therapeutics and Concurrent $50 Million Financing
Published: 2024-03-06 (Crawled : 12:30) - globenewswire.com
PPRUF | News | $361.9 37.56% 4.3K
|
Consumer Non-Durables
|
| O: 1.5%
H: 1.23%
C: 1.05%
PPRUY | News | $36.03 -0.11% 330K
|
Manufacturing
|
| O: 0.81%
H: 0.22%
C: -0.18%
PHGE | News | $0.2937 4.86% 0.1% 110K
|
Health Technology
|
| O: 211.55%
H: 18.75%
C: -4.46%
million therapeutics agreement
Vaxcyte Completes Enrollment of Phase 2 Study Evaluating VAX-24 for the Prevention of Invasive Pneumococcal Disease (IPD) in Infants
Published: 2024-03-04 (Crawled : 13:30) - globenewswire.com
PPRUF | News | $361.9 37.56% 4.3K
|
Consumer Non-Durables
|
| O: -0.59%
H: 0.27%
C: -1.83%
PPRUY | News | $36.03 -0.11% 330K
|
Manufacturing
|
| O: -1.85%
H: 0.2%
C: -0.07%
PCVX | $60.65 -2.85% -2.93% 660K
|
Health Technology
|
| O: 0.2%
H: 0.18%
C: -0.42%
STRO M | $3.76 -1.05% -1.06% 770K
|
Health Technology
|
| O: 0.2%
H: 1.81%
C: -3.43%
vax-24 disease pneumococcal study
Vaxcyte Looks to Raise $750M in Latest Public Offering
Published: 2024-02-02 (Crawled : 17:00) - biospace.com/
PPRUF | News | $361.9 37.56% 4.3K
|
Consumer Non-Durables
|
| O: -0.32%
H: 1.62%
C: 0.05%
PPRUY | News | $36.03 -0.11% 330K
|
Manufacturing
|
| O: -1.16%
H: 0.0%
C: -0.44%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -0.93%
H: 0.0%
C: 0.0%
offering
Vaxcyte Completes Enrollment of Phase 1/2 Study Evaluating VAX-31 for the Prevention of Invasive Pneumococcal Disease (IPD) in Adults Aged 50 and Older
Published: 2024-01-29 (Crawled : 13:30) - globenewswire.com
PPRUF | News | $361.9 37.56% 4.3K
|
Consumer Non-Durables
|
| O: 0.92%
H: 0.76%
C: -1.38%
PPRUY | News | $36.03 -0.11% 330K
|
Manufacturing
|
| O: -0.55%
H: 1.4%
C: 1.28%
PCVX | $60.65 -2.85% -2.93% 660K
|
Health Technology
|
| O: 0.26%
H: 6.59%
C: 6.23%
STRO M | $3.76 -1.05% -1.06% 770K
|
Health Technology
|
| O: -0.43%
H: 6.84%
C: 6.62%
vax-31 disease pneumococcal study
Vaxcyte Appoints Whitney Jones as Chief People Officer
Published: 2024-01-16 (Crawled : 21:00) - globenewswire.com
PPRUF | News | $361.9 37.56% 4.3K
|
Consumer Non-Durables
|
| O: -2.87%
H: 0.1%
C: -0.62%
PPRUY | News | $36.03 -0.11% 330K
|
Manufacturing
|
| O: -3.45%
H: 0.61%
C: 0.53%
PCVX | $60.65 -2.85% -2.93% 660K
|
Health Technology
|
| O: -1.81%
H: 3.73%
C: 3.69%
STRO M | $3.76 -1.05% -1.06% 770K
|
Health Technology
|
| O: -2.07%
H: 8.71%
C: 8.44%
jones
Vaxcyte Provides Clinical and Regulatory Progress Update on Potential Best-in-Class Pneumococcal Conjugate Vaccine (PCV) Franchise
Published: 2024-01-04 (Crawled : 21:00) - globenewswire.com
PPRUF | News | $361.9 37.56% 4.3K
|
Consumer Non-Durables
|
| O: -1.72%
H: 1.77%
C: -1.05%
PPRUY | News | $36.03 -0.11% 330K
|
Manufacturing
|
| O: -1.13%
H: 1.81%
C: 0.95%
PCVX | $60.65 -2.85% -2.93% 660K
|
Health Technology
|
| O: -2.53%
H: 0.56%
C: -4.66%
STRO M | $3.76 -1.05% -1.06% 770K
|
Health Technology
|
| O: -4.28%
H: 0.0%
C: -17.88%
pneumococcal vaccine update potential
Vaxcyte Appoints Jacks Lee to Board of Directors
Published: 2023-11-28 (Crawled : 14:00) - globenewswire.com
PPRUF | News | $361.9 37.56% 4.3K
|
Consumer Non-Durables
|
| O: -1.83%
H: 1.83%
C: -2.33%
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: -1.89%
H: 0.02%
C: 0.02%
PPRUY | News | $36.03 -0.11% 330K
|
Manufacturing
|
| O: -2.83%
H: 1.05%
C: 0.51%
PCVX | $60.65 -2.85% -2.93% 660K
|
Health Technology
|
| O: -1.82%
H: 1.91%
C: 1.75%
STRO M | $3.76 -1.05% -1.06% 770K
|
Health Technology
|
| O: 6.14%
H: 1.24%
C: -5.79%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -1.41%
H: 0.87%
C: 0.0%
GTHX | $4.16 -2.8% -2.88% 690K
|
Health Technology
|
| O: -0.61%
H: 4.91%
C: 3.68%
Vaxcyte Exercises Option and Enters into Manufacturing Rights Agreement with Sutro Biopharma to Obtain Control Over Manufacturing and Development of Cell-Free Extract for its Vaccine Candidates
Published: 2023-11-27 (Crawled : 21:00) - globenewswire.com
PPRUF | News | $361.9 37.56% 4.3K
|
Consumer Non-Durables
|
| O: -1.83%
H: 1.83%
C: -2.33%
PPRUY | News | $36.03 -0.11% 330K
|
Manufacturing
|
| O: -2.83%
H: 1.05%
C: 0.51%
PCVX | $60.65 -2.85% -2.93% 660K
|
Health Technology
|
| O: -1.82%
H: 1.91%
C: 1.75%
STRO M | $3.76 -1.05% -1.06% 770K
|
Health Technology
|
| O: 6.14%
H: 1.24%
C: -5.79%
vaccine control biopharma agreement
Vaxcyte Doses First Participants in Phase 1/2 Clinical Study Evaluating VAX-31 for the Prevention of Invasive Pneumococcal Disease in Adults
Published: 2023-11-09 (Crawled : 13:30) - globenewswire.com
PPRUF | News | $361.9 37.56% 4.3K
|
Consumer Non-Durables
|
| O: -1.41%
H: 1.77%
C: -1.32%
PPRUY | News | $36.03 -0.11% 330K
|
Manufacturing
|
| O: 1.28%
H: 0.21%
C: -1.4%
PCVX | $60.65 -2.85% -2.93% 660K
|
Health Technology
|
| O: 0.59%
H: 0.63%
C: -5.62%
STRO M | $3.76 -1.05% -1.06% 770K
|
Health Technology
|
| O: 4.12%
H: 0.0%
C: -11.07%
vax-31 disease pneumococcal study
Vaxcyte Reports Third Quarter 2023 Financial Results and Provides Business Update
Published: 2023-11-06 (Crawled : 21:00) - globenewswire.com
PPRUF | News | $361.9 37.56% 4.3K
|
Consumer Non-Durables
|
| O: 4.04%
H: 0.01%
C: -0.94%
PPRUY | News | $36.03 -0.11% 330K
|
Manufacturing
|
| O: -0.66%
H: 1.13%
C: 0.77%
PCVX | $60.65 -2.85% -2.93% 660K
|
Health Technology
|
| O: -0.52%
H: 7.4%
C: 4.69%
STRO M | $3.76 -1.05% -1.06% 770K
|
Health Technology
|
| O: 1.49%
H: 0.74%
C: -3.68%
business update financial results
Freshfields Builds US M&A Advisory Capability With Latham & … – Law.com International
Published: 2023-11-01 (Crawled : 10:00) - spacfeed.com
PPRUF | News | $361.9 37.56% 4.3K
|
Consumer Non-Durables
|
| O: -1.43%
H: 0.56%
C: -0.34%
PPRUY | News | $36.03 -0.11% 330K
|
Manufacturing
|
| O: -0.74%
H: 1.12%
C: 0.92%
HEPA | $2.1 -1.41% -1.43% 28K
|
Health Technology
|
| O: -3.85%
H: 4.23%
C: -2.0%
international
IPO Busts Have Lawyers Watching for Shareholder Stock Drop Suits – Bloomberg Law
Published: 2023-11-01 (Crawled : 10:00) - spacfeed.com
PPRUF | News | $361.9 37.56% 4.3K
|
Consumer Non-Durables
|
| O: -1.43%
H: 0.56%
C: -0.34%
PPRUY | News | $36.03 -0.11% 330K
|
Manufacturing
|
| O: -0.74%
H: 1.12%
C: 0.92%
HEPA | $2.1 -1.41% -1.43% 28K
|
Health Technology
|
| O: -3.85%
H: 4.23%
C: -2.0%
drop
Accenture boosts project consulting and healthcare marketing … – Investing.com
Published: 2023-11-01 (Crawled : 09:00) - spacfeed.com
PPRUF | News | $361.9 37.56% 4.3K
|
Consumer Non-Durables
|
| O: -1.43%
H: 0.56%
C: -0.34%
PPRUY | News | $36.03 -0.11% 330K
|
Manufacturing
|
| O: -0.74%
H: 1.12%
C: 0.92%
HEPA | $2.1 -1.41% -1.43% 28K
|
Health Technology
|
| O: -3.85%
H: 4.23%
C: -2.0%
VIC Acquistion Manager – Kering
Published: 2023-11-01 (Crawled : 08:00) - spacfeed.com
PPRUF | News | $361.9 37.56% 4.3K
|
Consumer Non-Durables
|
| O: -1.43%
H: 0.56%
C: -0.34%
PPRUY | News | $36.03 -0.11% 330K
|
Manufacturing
|
| O: -0.74%
H: 1.12%
C: 0.92%
HEPA | $2.1 -1.41% -1.43% 28K
|
Health Technology
|
| O: -3.85%
H: 4.23%
C: -2.0%
Aileron Therapeutics Announces Acquisition of Lung Therapeutics
Published: 2023-10-31 (Crawled : 20:00) - biospace.com/
PPRUF | News | $361.9 37.56% 4.3K
|
Consumer Non-Durables
|
| O: 2.15%
H: 0.59%
C: 0.59%
PPRUY | News | $36.03 -0.11% 330K
|
Manufacturing
|
| O: -0.56%
H: 0.2%
C: -0.2%
ALRN | $5.01 17.88% 15.17% 1.8M
|
Health Technology
|
| O: 2.26%
H: 20.23%
C: -6.22%
lung acquisition therapeutics
Vaxcyte Announces FDA Clearance of Investigational New Drug Application for VAX-31 for the Prevention of Invasive Pneumococcal Disease in Adults
Published: 2023-10-19 (Crawled : 12:30) - globenewswire.com
PPRUF | News | $361.9 37.56% 4.3K
|
Consumer Non-Durables
|
| O: -0.57%
H: 1.09%
C: 0.98%
PPRUY | News | $36.03 -0.11% 330K
|
Manufacturing
|
| O: 1.4%
H: 0.53%
C: -0.81%
PCVX | $60.65 -2.85% -2.93% 660K
|
Health Technology
|
| O: 0.24%
H: 2.54%
C: 0.78%
STRO M | $3.76 -1.05% -1.06% 770K
|
Health Technology
|
| O: -0.28%
H: 0.0%
C: -6.27%
vax-31 fda drug disease pneumococcal clearance application
Royalty Pharma Announces Agreement to Purchase Up to $1.5 Billion of PTC Therapeutics’ Royalty on Evrysdi
Published: 2023-10-19 (Crawled : 12:00) - globenewswire.com
PPRUF | News | $361.9 37.56% 4.3K
|
Consumer Non-Durables
|
| O: -0.57%
H: 1.09%
C: 0.98%
PPRUY | News | $36.03 -0.11% 330K
|
Manufacturing
|
| O: 1.4%
H: 0.53%
C: -0.81%
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: -0.73%
H: 0.0%
C: 0.0%
RPRX | $27.885 1.0% 0.99% 2.1M
|
Health Technology
|
| O: 0.15%
H: 3.45%
C: 2.22%
PTCT | $24.71 -1.79% -1.82% 820K
|
Health Technology
|
| O: 3.46%
H: 19.19%
C: 11.13%
pharma royalty evrysdi agreement
Apellis to Present Positive Phase 2 NOBLE Results of Pegcetacoplan in Post-Transplant Recurrence of Primary IC-MPGN and C3G at Kidney Week
Published: 2023-10-17 (Crawled : 11:00) - globenewswire.com
PPRUF | News | $361.9 37.56% 4.3K
|
Consumer Non-Durables
|
| O: -1.4%
H: 2.43%
C: 0.02%
PPRUY | News | $36.03 -0.11% 330K
|
Manufacturing
|
| O: -2.01%
H: 2.36%
C: 1.96%
APLS | $47.51 -1.08% -1.09% 1.9M
|
Health Technology
|
| O: 0.66%
H: 1.2%
C: -3.55%
kidney positive week results
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.